These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35840339)

  • 21. Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study.
    Koda K; Enomoto Y; Aoshima Y; Amano Y; Kato S; Hasegawa H; Matsui T; Yokomura K; Mochizuki E; Matsuura S; Koshimizu N; Morita M; Kojima S; Watanabe A; Oyama Y; Ikeda M; Kusagaya H; Uto T; Sato J; Imokawa S; Kono M; Hashimoto D; Kamiya Y; Toyoshima M; Asada K; Morita M; Mikamo M; Yasui H; Hozumi H; Karayama M; Suzuki Y; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suda T
    Ther Adv Chronic Dis; 2022; 13():20406223221108395. PubMed ID: 35782342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ILD-NSCLC-GAP index scoring and staging system for patients with non-small cell lung cancer and interstitial lung disease.
    Kobayashi H; Naito T; Omae K; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Murakami H; Endo M; Takahashi T
    Lung Cancer; 2018 Jul; 121():48-53. PubMed ID: 29858026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is operation safe for lung cancer patients with interstitial lung disease on computed tomography?
    Tang H; Ren Y; She Y; Dai C; Wang T; Su H; Sun W; Jiang G; Chen C
    Ther Adv Respir Dis; 2020; 14():1753466620971137. PubMed ID: 33167797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between Comorbidities and Acute Exacerbation of Interstitial Lung Disease after Primary Lung Cancer Surgery.
    Kato T; Miyoshi S; Hamada C; Sano Y; Nogami N; Yamaguchi O; Hamaguchi N
    Acta Med Okayama; 2023 Jun; 77(3):301-309. PubMed ID: 37357631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery.
    Takao S; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Medicine (Baltimore); 2019 Feb; 98(5):e14296. PubMed ID: 30702600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease.
    Kenmotsu H; Naito T; Mori K; Ko R; Ono A; Wakuda K; Imai H; Taira T; Murakami H; Endo M; Takahashi T
    Cancer Chemother Pharmacol; 2015 Mar; 75(3):521-6. PubMed ID: 25563718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re-hospitalisation predicts poor prognosis after acute exacerbation of interstitial lung disease.
    Salonen J; Jansa S; Vähänikkilä H; Kaarteenaho R
    BMC Pulm Med; 2023 Jul; 23(1):236. PubMed ID: 37393286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exacerbation of bleomycin-induced injury by lipopolysaccharide in mice: establishment of a mouse model for acute exacerbation of interstitial lung diseases.
    Kimura T; Nojiri T; Hosoda H; Shintani Y; Inoue M; Miyazato M; Okumura M; Kangawa K
    Eur J Cardiothorac Surg; 2015 Oct; 48(4):e85-91. PubMed ID: 26224340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows.
    Takahara Y; Tanaka T; Ishige Y; Shionoya I; Yamamura K; Sakuma T; Nishiki K; Nakase K; Nojiri M; Kato R; Shinomiya S; Fujimoto Y; Oikawa T; Mizuno S
    Thorac Cancer; 2021 Oct; 12(20):2758-2766. PubMed ID: 34409749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Related factors, increased mortality and causes of death in patients with rheumatoid arthritis-associated interstitial lung disease.
    Kakutani T; Hashimoto A; Tominaga A; Kodama K; Nogi S; Tsuno H; Ogihara H; Nunokawa T; Komiya A; Furukawa H; Tohma S; Matsui T
    Mod Rheumatol; 2020 May; 30(3):458-464. PubMed ID: 31116052
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
    Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
    Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nintedanib administration after the onset of acute exacerbation of interstitial lung disease in the real world.
    Kato M; Sasaki S; Mori W; Kohmaru M; Akimoto T; Hayakawa E; Soma S; Arai Y; Matsubara NS; Nakazawa S; Sueyasu T; Hirakawa H; Motomura H; Sumiyoshi I; Ochi Y; Watanabe J; Hoshi K; Kadoya K; Ihara H; Hou J; Togo S; Takahashi K
    Sci Rep; 2023 Aug; 13(1):12528. PubMed ID: 37532874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
    Hozumi H; Kono M; Hasegawa H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
    Chest; 2021 Jun; 159(6):2334-2345. PubMed ID: 33571506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
    Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
    Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease].
    Huang C; Ma C; Wu Q; Jiao P; Sun Y; Tian W; Yu H; Huang W; Wang Y; Tong H
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):343-350. PubMed ID: 32429636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticancer drug treatment for advanced lung cancer with interstitial lung disease.
    Otsubo K; Okamoto I; Hamada N; Nakanishi Y
    Respir Investig; 2018 Jul; 56(4):307-311. PubMed ID: 29764748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New risk scoring system for predicting acute exacerbation of interstitial pneumonia after chemotherapy for lung cancer associated with interstitial pneumonia.
    Isobe K; Kaburaki K; Kobayashi H; Sano G; Sakamoto S; Takai Y; Makino T; Tochigi N; Iyoda A; Homma S
    Lung Cancer; 2018 Nov; 125():253-257. PubMed ID: 30429029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of S-1 in combination with carboplatin in non-small cell lung cancer patients with interstitial lung disease: a pilot study.
    Sekine A; Satoh H; Baba T; Ikeda S; Okuda R; Shinohara T; Komatsu S; Hagiwara E; Iwasawa T; Ogura T; Kato T
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1245-52. PubMed ID: 27130459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of collagen vascular disease-associated interstitial lung disease on the outcomes of lung cancer surgery.
    Maeda H; Kanzaki M; Sakamoto K; Isaka T; Oyama K; Murasugi M; Onuki T
    Surg Today; 2017 Sep; 47(9):1072-1079. PubMed ID: 28247107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.